Document Detail

Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker.
MedLine Citation:
PMID:  21315119     Owner:  NLM     Status:  Publisher    
Polylysine dendrimers have potential as biodegradable vectors for the delivery of cytotoxic drugs to solid tumours. Here, the cytotoxicity, drug release and tumour targeting properties of Generation 5 PEGylated polylysine dendrimers comprising an outer generation of L-lysine or succinimyldipropyldiamine (SPN) and containing doxorubicin (DOX) linked through an acid labile 4-(hydrazinosulfonyl) benzoic acid (HSBA) linker have been characterised. Less than 10% of the DOX load was released from LYS or SPN dendrimers in pH 7.4 buffer over 3days. In contrast approximately 100% release was evident at pH 5. The DOX-conjugated dendrimers also retained similar cytotoxic properties to free DOX in in vitro cell culture studies (presumably as a result of in situ liberation of free DOX). The clearance patterns of the DOX conjugated SPN and all-lysine dendrimers were similar to the equivalent non-DOX conjugated systems, however the SPN dendrimers showed reduced metabolic lability and increased uptake into RES organs when compared to the equivalent all-lysine dendrimers. In vivo assessment of the DOX-conjugated, PEGylated polylysine dendrimers (both SPN and LYS constructs) in rats bearing Walker 256 tumours revealed higher uptake into tumour tissue when compared with control tissue such as muscle (~8 fold) and heart (~3 fold). The data suggest that polylysine dendrimers containing DOX conjugated via an acid labile HSBA linker may provide a mechanism to target the delivery of DOX to tumours.
Lisa M Kaminskas; Brian D Kelly; Victoria M McLeod; Gian Sberna; David J Owen; Ben J Boyd; Christopher J H Porter
Related Documents :
16824509 - Changes in brain interleukin-1beta following the coadministration of norfloxacin with b...
9778579 - Metabolic control of kynurenic acid formation in the rat brain.
10984109 - N-3 fatty acid deficiency decreases phosphatidylserine accumulation selectively in neur...
20504399 - Effects of caffeine on amino acid transport in the brain.
1185179 - Viability of some metabolic processes in the isolated toad brain adapted to two osmotic...
7087669 - Effect of infusing the branched-chain amino acids on concentrations of amino acids in p...
1245579 - Preparation, separation and degradation of oligouronides produced by the polygalacturon...
12520449 - Hydrolysis of proteins with methanesulfonic acid for improved hplc-icp-ms determination...
11518719 - Identification of a new class of molecules, the arachidonyl amino acids, and characteri...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-8
Journal Detail:
Title:  Journal of controlled release : official journal of the Controlled Release Society     Volume:  -     ISSN:  1873-4995     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8607908     Medline TA:  J Control Release     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2010. Published by Elsevier B.V.
Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville campus), 381 Royal Pde, Parkville, VIC, 3052, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bone reservoir: Injectable hyaluronic acid hydrogel for minimal invasive bone augmentation.
Next Document:  Selective gene transfection of individual cells in vitro with plasmonic nanobubbles.